Bay Biosciences provides FFPE tissue blocks with matched serum and plasma bio-fluid samples from treatment-naive patients with Renal Cell Carcinoma (RCC).

Moreover, samples are processed using customized protocols provided by the customer.

In addition, fresh whole-blood from patients diagnosed with renal cell carcinoma (RCC) is used to process the serum and samples.

 

Renal cell carcinoma (RCC) Overview

Renal cell carcinoma (RCC), also known as hypernephroma, renal adenocarcinoma, or renal or kidney cancer. Moreover, RCC is the most common type of kidney cancer found in adults.

Furthermore, the kidneys are organs that help in the elimination of waste while, at the same time, regulating fluid balance. In addition, tiny tubes called tubules exist within the kidneys, thereby aiding in blood filtration, waste excretion, and urine production.

RCC arises when, consequently, cancer cells begin to grow uncontrollably in the lining of the kidney’s tubules. Notably, this cancer is characterized by its rapid growth. In addition, its tendency to metastasize to the lungs and surrounding organs.

Causes of Renal cell carcinoma (RCC)

The exact causes of Renal cell carcinoma (RCC) are unknown. However, men between the ages of 50 and 70 mostly develop RCC cancer, yet anyone can be diagnosed with it.

Furthermore, the following are some of the common risk factors for Renal cell carcinoma (RCC):

  • Firstly, a family history of Renal cell carcinoma (RCC)
  • Additionally, dialysis treatment
  • Moreover, hypertension
  • In addition, obesity
  • Also, Smoking cigarettes
  • Likewise, polycystic kidney disease, an inherited disorder that causes cysts to form in the kidneys.
  • Furthermore, the genetic condition Von Hippel-Lindau disease, characterized by cysts and tumors in various organs.
  • Lastly, chronic abuse of certain prescribed and over-the-counter medications such as non-steroidal anti-inflammatory drugs (NSAIDs).